Saiid Zarrabian is Head of Strategic Partnerships of Kintara Therapeutics, Inc.. Currently has a direct ownership of 55,500 shares of KTRA, which is worth approximately $9,990. The most recent transaction as insider was on Dec 07, 2021, when has been sold 38,109 shares (Common Stock) at a price of $0.64 per share, resulting in proceeds of $24,390. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.5K
0% 3M change
0% 12M change
Total Value Held $9,990

Saiid Zarrabian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2021
BUY
Open market or private purchase
$24,390 $0.64 p/Share
38,109 Added 40.71%
55,500 Common Stock
Dec 06 2021
BUY
Open market or private purchase
$7,016 $0.59 p/Share
11,891 Added 40.61%
17,391 Common Stock
SZ

Saiid Zarrabian

Head of Strategic Partnerships
San Diego, CA

Track Institutional and Insider Activities on KTRA

Follow Kintara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTRA shares.

Notify only if

Insider Trading

Get notified when an Kintara Therapeutics, Inc. insider buys or sells KTRA shares.

Notify only if

News

Receive news related to Kintara Therapeutics, Inc.

Track Activities on KTRA